HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The coding polymorphism T263I in TGF-beta1 is associated with otosclerosis in two independent populations.

Abstract
Otosclerosis is a progressive hearing loss characterized by an abnormal bone homeostasis of the otic capsule that leads to stapes fixation. Although its etiology remains unknown, otosclerosis can be considered a complex disease. Transforming growth factor-beta 1 (TGF-beta1) was chosen for a case-control association study, because of several non-genetic indications of involvement in otosclerosis. Single nucleotide polymorphism (SNP) analysis in a large Belgian-Dutch sample set gave significant results (P = 0.0044) for an amino acid changing SNP, T263I. Analysis of an independent French population replicated this association with SNP T263I (P = 0.00019). The results remained significant after multiple testing correction in both populations. Haplotype analysis and the results of an independent effect test using the weighted haplotype (WHAP) computer program in both populations were both compatible with SNP T263I being the only causal variant. The variant I263 is under-represented in otosclerosis patients and hence protective against the disease. Combining the data of both case-control groups for SNP T263I with a Mantel-Haenszel estimate of common odds ratios gave a very significant result (P = 9.2 x 10(-6)). Functional analysis of SNP T263I with a luciferase reporter assay showed that the protective variant I263 of TGF-beta1 is more active than the WT variant T263 (P = 1.6 x 10(-6)). On the basis of very low P-values, replication in an independent population and a functional effect of the protective variant, we conclude that TGF-beta1 influences the susceptibility for otosclerosis, and that the I263 variant is protective against the disease.
AuthorsMelissa Thys, Isabelle Schrauwen, Kathleen Vanderstraeten, Katrien Janssens, Nele Dieltjens, Kris Van Den Bogaert, Erik Fransen, Wenjie Chen, Megan Ealy, Mireille Claustres, Cor R W J Cremers, Ingeborg Dhooge, Frank Declau, Jos Claes, Paul Van de Heyning, Robert Vincent, Thomas Somers, Erwin Offeciers, Richard J H Smith, Guy Van Camp
JournalHuman molecular genetics (Hum Mol Genet) Vol. 16 Issue 17 Pg. 2021-30 (Sep 01 2007) ISSN: 0964-6906 [Print] England
PMID17588962 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • TGFB1 protein, human
  • Transforming Growth Factor beta1
Topics
  • Amino Acid Substitution
  • Case-Control Studies
  • Disease Susceptibility
  • Genetic Variation
  • Genetics, Population
  • Genotype
  • Haplotypes
  • Humans
  • Models, Biological
  • Otosclerosis (ethnology, etiology, genetics)
  • Phenotype
  • Polymorphism, Single Nucleotide
  • Sequence Analysis, DNA
  • Transforming Growth Factor beta1 (genetics)
  • White People

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: